Allergy & Immunology Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Allergy, Asthma, and Atopic Eczema in Finland
Conditions: Asthma; Asthma in Children; Allergy; Rhinitis, Allergic; Atopic Dermatitis; Allergen Immunotherapy Interventions: Other: No intervention Sponsors: Tampere University; Professor Lauri Lehtim äki; Professor Mika Mäkelä; Professor Sanna Toppila-Salmi; Professor Ilkka Junttila Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials

TREATment of Lower Respiratory Tract Infection in Sri Lanka (TREAT-SL)
Conditions: Lower Resp Tract Infection Interventions: Other: electronic clinical decision support tool (eCDST) diagnostic plan Sponsors: Duke University; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials

Efficacy of Cashew Nut Protein Immunotherapy
Conditions: Food Allergy Interventions: Combination Product: Cashew immunotherapy Sponsors: Medical University of Warsaw Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials

A Prospective Birth Cohort of Infants With Allergy and Neurodevelopmental Disorders in China
Conditions: Child Allergy; Neurodevelopmental Disorders Sponsors: Qilu Hospital of Shandong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials

Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease
Conditions: Chronic Granulomatous Disease (CGD); X-Linked Chronic Granulomatous Disease Interventions: Biological: Base-edited hematopoietic stem and progenitor cells; Drug: Busulfan; Drug: Palifermin; Drug: Filgrastim; Drug: Plerixafor Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials

Clinical and Immunological Evaluation of HA in Treatment of Periodontitis
Conditions: Periodontitis Interventions: Drug: Hyaluronic acid; Behavioral: scaling and root planning Sponsors: Sana ' a University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials

HI-Bio Receives FDA Orphan Drug Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection (AMR) in Kidney Transplant Recipients
SOUTH SAN FRANCISCO, Calif.,– March 21, 2024– Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), today announced... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 21, 2024 Category: Pharmaceuticals Source Type: clinical trials

Efficacy and Safety of Auricular Acupressure in Treating Allergic Rhinitis
Conditions: Itching; Runny Nose; Sneezing; Nasal Congestion Interventions: Other: Auricular acupressure; Other: Sham acupressure; Other: Standard treatment Sponsors: University of Medicine and Pharmacy at Ho Chi Minh City Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials

Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma
Conditions: Mild Allergic Asthma Interventions: Other: allergen challenge Sponsors: Fraunhofer-Institute of Toxicology and Experimental Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials

A Study of IL4R α Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR).
Conditions: Allergic Rhinitis Interventions: Biological: GR1802 injection; Biological: Placebo Sponsors: Genrix (Shanghai) Biopharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials

Omalizumab in Severe Asthmatics With Food Allergy
Conditions: Food; Allergy, Anaphylactic Shock; Asthma in Children Interventions: Biological: Omalizumab Sponsors: Bambino Ges ù Hospital and Research Institute Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials

Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge
Conditions: Penicillin Allergy Interventions: Drug: Amoxicillin 250 MG; Drug: Placebo; Drug: Amoxicillin 62.5mg; Drug: Amoxicillin 187.5mg Sponsors: James Tarbox, MD; Texas Tech University Health Sciences Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project
Conditions: Atopic Dermatitis; Food Allergy; Healthy Interventions: Other: Data and biospecimen collection; Other: Skin biopsies; Other: Oral Food Challenge (OFC) procedures Sponsors: University of Michigan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials

Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis
Conditions: Seasonal Allergic Rhinitis Interventions: Biological: Interleukin-4 receptor responders; Other: Placebo Sponsors: Beijing Tongren Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials

Analysing HIgh Dose Probiotic Peanut Oral Immunotherapy (PPOIT) and High Dose Peanut Oral Immunotherapy (OIT) Versus LOw Dose Peanut OIT for Peanut Allergy
Conditions: Peanut Allergy Interventions: Drug: Peanut Oral Powder [PEANUT POWDER]; Dietary Supplement: Probiotic (LGG ®, Lactobacillus Rhamnosus) or placebo probiotic (maltodextrin) Sponsors: Murdoch Childrens Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials